2007, Clinical Trials, Data and Epilepsy

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2007

Clinical Trials

Data

Epilepsy

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

NOVEMBER 24, 2021

At the same time, the outlook on cannabis research data is largely positive. Chronic pain or pain were the conditions most frequently mentioned in articles about cannabis, followed by epilepsy, cancer or cancer pain, and nausea and chemotherapy. Refractory paediatric epilepsy. Palliative care indications. Cancer pain.

Research and Development

Research and Development Medicine Access Media

Report: “Key pharmacological differences between side effects of refined, pharmaceutical CBD formulations and whole plant extracts:”

Cannabis Law Report

JULY 12, 2019

Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval. Lancet Neurol Dec 23 2015.

Extraction

Extraction Pharmaceutical CBD Epilepsy

Medical Cannabis Brief

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Report: “Key pharmacological differences between side effects of refined, pharmaceutical CBD formulations and whole plant extracts:”

Stay Connected